HUNAN FANGSHENG PHARMACEUTICAL CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.82 CNY | +2.07% |
|
+4.88% | +7.85% |
| Apr. 19 | Hunan Fangsheng Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Apr. 10 | Fangsheng Pharma's Factories Pass GMP Inspection | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Hunan FangshengPharmaceutical Co., Ltd. is a China-based company principally engaged in the research, development, production and sale of cardiovascular medicine, orthopedic medicine, pediatric medicine, gynecological medicine and anti-infective medicine. The Company's main products include Xuesaitong Dispersible Tablets, Xuesaitong Tablets, Tenghuang Jiangu Tablets, Dieda Huoxue Capsules, Lysine Dimension B12 Granules, Cefixoxime Tablets and Jinying Capsules. The Company distributes its products primarily in domestic market.
Sector
Pharmaceuticals
Calendar
2024-05-14
- Annual General Meeting
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
11.82
CNY
Average target price
10.31
CNY
Spread / Average Target
-12.77%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +7.85% | 718M | |
| +20.61% | 43.18B | |
| +20.67% | 22.59B | |
| +14.56% | 14.56B | |
| +13.94% | 13.54B | |
| +43.35% | 11.5B | |
| -8.37% | 6.93B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +10.21% | 5.36B |
- Stock Market
- Equities
- 603998 Stock
- News Hunan Fangsheng Pharmaceutical Co., Ltd.
- Fangsheng Pharma's Factories Pass GMP Inspection
